13F HOLDINGS REPORT
RA CAPITAL MANAGEMENT, L.P.
Quarter ended Q4 2024 · Filed February 14, 2025 · Accession 0001104659-25-014181
Total Value
$7.51B
Positions
90
Other Managers
0
Confidential Omitted
No
Holdings (90)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | ASCENDIS PHARMA A/S - ADR | ASND | 10,112,744 | $1.39B | 18.53% |
| 2 | VAXCYTE INC | PCVX | 8,689,190 | $711.3M | 9.47% |
| 3 | JANUX THERAPEUTICS INC | JANX | 10,365,652 | $555.0M | 7.39% |
| 4 | RHYTHM PHARMACEUTICALS INC | RYTM | 6,084,412 | $340.6M | 4.53% |
| 5 | LEGEND BIOTECH CORP-ADR | LEGN | 7,506,934 | $244.3M | 3.25% |
| 6 | EDGEWISE THERAPEUTICS INC | EWTX | 8,909,091 | $237.9M | 3.17% |
| 7 | NEWAMSTERDAM PHARMA CO NV | NAMSW | 8,845,000 | $227.3M | 3.03% |
| 8 | WAVE LIFE SCIENCES LTD | WVE | 18,202,009 | $225.2M | 3.00% |
| 9 | ARCELLX INC | ACLX | 2,787,327 | $213.8M | 2.84% |
| 10 | AVIDITY BIOSCIENCES INC | 05370A108 | 6,300,408 | $183.2M | 2.44% |
| 11 | SEPTERNA INC | SEPN | 6,995,858 | $160.2M | 2.13% |
| 12 | DYNE THERAPEUTICS INC | DYN | 6,381,144 | $150.3M | 2.00% |
| 13 | TYRA BIOSCIENCES INC | TYRA | 10,637,290 | $147.9M | 1.97% |
| 14 | RXSIGHT INC | RXST | 3,743,018 | $128.7M | 1.71% |
| 15 | BICARA THERAPEUTICS INC | BCAX | 6,955,993 | $121.2M | 1.61% |
| 16 | LENZ THERAPEUTICS INC | LENZ | 4,178,823 | $120.6M | 1.61% |
| 17 | ARS PHARMACEUTICALS INC | SPRY | 10,860,977 | $114.6M | 1.52% |
| 18 | 89BIO INC | 282559103 | 14,175,398 | $110.9M | 1.48% |
| 19 | SPDR S&P BIOTECH ETF | 78464A870 | 1,228,240 | $110.6M | 1.47% |
| 20 | GERON CORP | GERN | 30,009,536 | $106.2M | 1.41% |
| 21 | ARTIVA BIOTHERAPEUTICS INC | ARTV | 9,853,302 | $99.3M | 1.32% |
| 22 | AXSOME THERAPEUTICS INC | AXSM | 1,000,000 | $84.6M | 1.13% |
| 23 | VERONA PHARMA PLC - ADR | 925050106 | 1,766,830 | $82.1M | 1.09% |
| 24 | DAY ONE BIOPHARMACEUTICALS I | DAWN | 5,755,577 | $72.9M | 0.97% |
| 25 | APOGEE THERAPEUTICS INC | APGE | 1,569,491 | $71.1M | 0.95% |
| 26 | MINERALYS THERAPEUTICS INC | MLYS | 4,850,984 | $59.7M | 0.79% |
| 27 | PRAXIS PRECISION MEDICINES I | PRAX | 761,955 | $58.6M | 0.78% |
| 28 | RECURSION PHARMACEUTICALS-A | RXRX | 7,725,096 | $52.2M | 0.69% |
| 29 | CLIMB BIO INC | CLYM | 28,939,395 | $52.1M | 0.69% |
| 30 | TOURMALINE BIO INC | 89157D105 | 2,538,925 | $51.5M | 0.69% |
| 31 | ACRIVON THERAPEUTICS INC | ACRV | 8,340,508 | $50.2M | 0.67% |
| 32 | FULCRUM THERAPEUTICS INC | FULC | 10,229,099 | $48.1M | 0.64% |
| 33 | 10X GENOMICS INC-CLASS A | TXG | 3,279,401 | $47.1M | 0.63% |
| 34 | GH RESEARCH PLC | GHRS | 6,686,689 | $46.8M | 0.62% |
| 35 | ASTRIA THERAPEUTICS INC | 04635X102 | 5,105,213 | $45.6M | 0.61% |
| 36 | VOR BIOPHARMA INC | VOR | 39,646,039 | $44.0M | 0.59% |
| 37 | STRUCTURE THERAPEUTICS INC | GPCR | 1,517,418 | $41.2M | 0.55% |
| 38 | DIANTHUS THERAPEUTICS INC | DNTH | 1,866,400 | $40.7M | 0.54% |
| 39 | PEPGEN INC | PEPG | 10,689,545 | $40.5M | 0.54% |
| 40 | EVOLENT HEALTH INC - A | EVH | 3,577,197 | $40.2M | 0.54% |
| 41 | KURA ONCOLOGY INC | KURA | 4,451,041 | $38.8M | 0.52% |
| 42 | IDEAYA BIOSCIENCES INC | IDYA | 1,347,252 | $34.6M | 0.46% |
| 43 | ZAI LAB LTD-ADR | ZLAB | 1,295,040 | $33.9M | 0.45% |
| 44 | CHIMERIX INC | 16934W106 | 8,800,000 | $30.6M | 0.41% |
| 45 | CIDARA THERAPEUTICS INC | 171757206 | 1,092,796 | $29.4M | 0.39% |
| 46 | MBX BIOSCIENCES INC | MBX | 1,511,334 | $27.9M | 0.37% |
| 47 | NKARTA INC | NKTX | 10,805,129 | $26.9M | 0.36% |
| 48 | ACUMEN PHARMACEUTICALS INC | ABOS | 14,932,063 | $25.7M | 0.34% |
| 49 | 4D MOLECULAR THERAPEUTICS IN | FDMT | 4,563,211 | $25.4M | 0.34% |
| 50 | NURIX THERAPEUTICS INC | NRIX | 1,333,333 | $25.1M | 0.33% |
| 51 | SERA PROGNOSTICS INC-A | SERA | 3,032,808 | $24.7M | 0.33% |
| 52 | AEROVATE THERAPEUTICS INC | 008064107 | 9,192,092 | $24.4M | 0.32% |
| 53 | EYEPOINT PHARMACEUTICALS INC | EYPT | 3,181,818 | $23.7M | 0.32% |
| 54 | LARIMAR THERAPEUTICS INC | LRMR | 6,045,351 | $23.4M | 0.31% |
| 55 | CERIBELL INC | CBLL | 824,582 | $21.3M | 0.28% |
| 56 | TRAVERE THERAPEUTICS INC | TVTX | 1,150,000 | $20.0M | 0.27% |
| 57 | ENLIVEN THERAPEUTICS INC | ELVN | 848,986 | $19.1M | 0.25% |
| 58 | TAYSHA GENE THERAPIES INC | TSHA | 10,872,503 | $18.8M | 0.25% |
| 59 | ALECTOR INC | ALEC | 9,695,228 | $18.3M | 0.24% |
| 60 | PROTARA THERAPEUTIC INC | TARA | 3,400,000 | $18.0M | 0.24% |
| 61 | C4 THERAPEUTICS INC | CCCC | 4,878,000 | $17.6M | 0.23% |
| 62 | SOLID BIOSCIENCES INC | SLDB | 4,330,446 | $17.3M | 0.23% |
| 63 | PLIANT THERAPEUTICS INC | PLRX | 1,281,000 | $16.9M | 0.22% |
| 64 | Bright Minds Biosciences Inc | DRUG | 460,829 | $16.6M | 0.22% |
| 65 | ITEOS THERAPEUTICS INC | 46565G104 | 2,092,259 | $16.1M | 0.21% |
| 66 | BICYCLE THERAPEUTICS PLC-ADR | BCYC | 1,093,477 | $15.3M | 0.20% |
| 67 | ELEDON PHARMACEUTICALS INC | ELDN | 3,566,338 | $14.7M | 0.20% |
| 68 | INSMED INC | INSM | 200,000 | $13.8M | 0.18% |
| 69 | XENCOR INC | XNCR | 575,000 | $13.2M | 0.18% |
| 70 | IMMATICS NV | IMTX | 1,750,000 | $12.4M | 0.17% |
| 71 | ACLARIS THERAPEUTICS INC | ACRS | 4,666,667 | $11.6M | 0.15% |
| 72 | MONOPAR THERAPEUTICS INC | MNPR | 511,207 | $11.2M | 0.15% |
| 73 | THIRD HARMONIC BIO INC | 88427A107 | 960,620 | $9.9M | 0.13% |
| 74 | WEREWOLF THERAPEUTICS INC | HOWL | 6,144,881 | $9.1M | 0.12% |
| 75 | ARVINAS INC | ARVN | 421,348 | $8.1M | 0.11% |
| 76 | ZURA BIO LTD | ZURA | 3,217,503 | $8.0M | 0.11% |
| 77 | PERCEPTIVE CAPITAL SOLUTIONS | G70077105 | 750,000 | $7.6M | 0.10% |
| 78 | BIOAGE LABS INC | BIOA | 1,310,589 | $7.6M | 0.10% |
| 79 | ADICET BIO INC | ACET | 7,541,000 | $7.3M | 0.10% |
| 80 | AVALO THERAPEUTICS INC | AVTX | 967,000 | $7.2M | 0.10% |
| 81 | BOUNDLESS BIO INC | BOLD | 2,180,631 | $6.3M | 0.08% |
| 82 | ENANTA PHARMACEUTICALS INC | ENTA | 1,038,000 | $6.0M | 0.08% |
| 83 | NEWAMSTERDAM PHARMA CO NV-27 | NAMSW | 333,333 | $4.7M | 0.06% |
| 84 | CLIMB BIO INC | CLYM | 2,479,872 | $4.5M | 0.06% |
| 85 | SURROZEN INC | SRZNW | 282,580 | $4.1M | 0.05% |
| 86 | LEXEO THERAPEUTICS INC | LXEO | 546,554 | $3.6M | 0.05% |
| 87 | ALLAKOS INC | 01671P100 | 1,129,931 | $1.4M | 0.02% |
| 88 | SCHOLAR ROCK HOLDING CORP | SRRK | 17,616 | $761,364 | 0.01% |
| 89 | REGULUS THERAPEUTICS INC | 75915K309 | 336,843 | $532,212 | 0.01% |
| 90 | SCILEX HOLDING CO | SCLXW | 1,036,218 | $441,843 | 0.01% |